cd38

  1. Kalliope

    Open Norway: Plasma cell aimed treatment with daratumumab in ME/CFS - Haukeland University Hospital

    The ME/CFS research team at Haukeland University Hospital in Bergen, Norway (Fluge, Mella, Rekeland, Sørland etc) is recruiting 66 participants for a new placebo-controlled trial on Daratumumab as a potential treatment for ME/CFS. The duration for participants is 72 weeks. The participants will...
  2. J

    Daratumumab, isatuximab (CD38 drugs)

    Commercialisation of HLX15 (daratumumab) https://www.businesswire.com/news/home/20250206161649/en/Dr.-Reddy’s-enters-into-collaboration-with-Henlius-for-commercialization-of-HLX15-daratumumab-a-biosimilar-candidate-to-Darzalex®-Darzalex-Faspro®-in-the-U.S.-and-Europe
Back
Top Bottom